Td Asset Management Inc Amgen Inc Transaction History

Td Asset Management Inc

$102 Billion
Q2 2024

A detailed history of Td Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Td Asset Management Inc holds 584,546 shares of AMGN stock, worth $185 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

584,546

Previous 535,973 9.06%

Holding current value

$185 Million

Previous $152 Million 19.85%

% of portfolio

0.18%

Previous 0.15%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $12.8 Million - $15.5 Million	48,573 Added 9.06%	584,546 $183 Million
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $7.22 Million - $8.71 Million	-26,839 Reduced 4.77%	535,973 $152 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $3.47 Million - $3.92 Million	-13,577 Reduced 2.36%	562,812 $162 Million
Q3 2023 Oct 27, 2023	BUY	$218.65 - $271.46 $31.3 Million - $38.8 Million	143,109 Added 33.03%	576,389 $155 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $4.89 Million - $5.79 Million	-22,835 Reduced 5.01%	433,280 $96.2 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $1.07 Million - $1.3 Million	4,734 Added 1.05%	456,115 $110 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $3.66 Million - $4.65 Million	-15,966 Reduced 3.42%	451,381 $119 Million
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $2.12 Million - $2.39 Million	9,430 Added 2.06%	467,347 $107 Million
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $15.8 Million - $17.6 Million	-68,374 Reduced 12.99%	457,917 $111 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $1.26 Million - $1.39 Million	5,737 Added 1.1%	526,291 $127 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $2.07 Million - $2.36 Million	-10,384 Reduced 1.96%	520,554 $117 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $564,001 - $660,795	-2,657 Reduced 0.5%	530,938 $113 Million
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $3.86 Million - $4.29 Million	-16,538 Reduced 3.01%	533,595 $129 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $8.45 Million - $9.85 Million	38,077 Added 7.44%	550,133 $137 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $10.7 Million - $12.8 Million	49,584 Added 10.72%	512,056 $118 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $19.6 Million - $21.7 Million	83,340 Added 21.98%	462,472 $118 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $13.3 Million - $16.3 Million	-67,148 Reduced 15.05%	379,132 $89.4 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $960,587 - $1.27 Million	-5,271 Reduced 1.17%	446,280 $90.5 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $1.24 Million - $1.6 Million	-6,569 Reduced 1.43%	451,551 $109 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $11.8 Million - $14.2 Million	68,020 Added 17.44%	458,120 $88.7 Million
Q2 2019 Aug 01, 2019	BUY	$166.7 - $195.41 $6.72 Million - $7.88 Million	40,310 Added 11.52%	390,100 $71.9 Million
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $53.5 Million - $60.3 Million	-295,990 Reduced 45.83%	349,790 $66.5 Million
Q4 2018 Feb 01, 2019	BUY	$178.4 - $208.25 $5.88 Million - $6.86 Million	32,943 Added 5.38%	645,780 $126 Million
Q3 2018 Nov 01, 2018	SELL	$185.29 - $208.89 $8.7 Million - $9.81 Million	-46,959 Reduced 7.12%	612,837 $127 Million
Q2 2018 Jul 31, 2018	BUY	$166.05 - $186.51 $19 Million - $21.3 Million	114,125 Added 20.91%	659,796 $122 Million
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $229,916 - $268,686	1,357 Added 0.25%	545,671 $93 Million
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $1.25 Million - $1.39 Million	-7,384 Reduced 1.34%	544,314 $94.7 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $92.3 Million - $105 Million	551,698	551,698 $103 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Amgen Inc Transaction History